Merakris Therapeutics
PrivateCompany Overview
Merakris Therapeutics operates in Healthcare & Life Sciences and is based in North Carolina. It was founded in 2016.
Merakris Therapeutics is a biotechnology company that researches, develops, and commercializes regenerative healthcare products for wound care.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Merakris Therapeutics Comparables
Compare Merakris Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Skye Biologics Holdings | 84% | |
| BIOHEAL Therapeutics | 80% | |
| BioStem Technologies Inc | 77% |
For institutional investors. Book with your work email.
Merakris Therapeutics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2026
Monthly visitors grew 71% MoM, reaching 4.9K.
- Sep 4, 2025
Attending SAWC Fall 2025 to highlight clinical programs.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withSep 8, 2026
Merakris Therapeutics, Inc. and 360 Medical partner to commercialize and distribute patent-pending AmnioSurge, with planned collaboration on sales-force development, surgeon education, and procedural training for robotic and open colorectal workflows in North Carolina on Sep 8th '26.
- launchesSep 8, 2026
Merakris Therapeutics, Inc. commercially launches patent-pending AmnioSurge(TM), a sterile full-thickness amnion/chorion allograft designed as a protective covering or barrier at colorectal and other internal anastomotic sites, with 360 Medical in North Carolina on Sep 8th '26.
For institutional investors. Book with your work email.
Merakris Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Merakris Therapeutics's valuation, stock price, and market status.
Is Merakris Therapeutics a public or private company?
Merakris Therapeutics is a private company.
What is the current stock price of Merakris Therapeutics?
Merakris Therapeutics is a private company, so its shares have no public market price. Caplight tracks Merakris Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Merakris Therapeutics worth (valuation)?
Valuation information for Merakris Therapeutics is not publicly available.
Can I buy Merakris Therapeutics stock?
Merakris Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Merakris Therapeutics's last funding round?
Funding round information for Merakris Therapeutics is not publicly available.
Who are the main investors in Merakris Therapeutics?
Investor information for Merakris Therapeutics is not publicly disclosed.
Will Merakris Therapeutics IPO soon?
No public IPO plans have been announced for Merakris Therapeutics.
How can I track Merakris Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Merakris Therapeutics's shares on secondary markets.